Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDC To Review Intussusception Cases With Vaccines Other Than RotaShield

Executive Summary

The Centers for Disease Control & Prevention is conducting a retrospective review to determine whether intussusception is associated with vaccines other than Wyeth-Ayerst's RotaShield.

You may also be interested in...

RotaShield Data On Intussusception May Be Ready By October

Wyeth-Ayerst may have additional information on the relationship between RotaShield and intussusception from a multi-state case control study in time for the next CDC Advisory Committee on Immunization Practices meeting in October.

CDC Advocates All-IPV Immunization Schedule; Combo Development Heats Up

The move to a CDC-recommended all-IPV dosing schedule will create shifts in the multi-component pediatric vaccine market as well as support for Pasteur Merieux Connaught's inactivated polio vaccine.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts